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ABSTRACT OF THE THESIS 
ENZYME CATALYZED AND ULTRASOUND ASSISTED 
TRANSFORMATION OF SELECTED POLLUTANTS 
by 
Yi Tan 
Florida International University, 2017 
Miami, Florida 
Professor Xiaotang Wang, Co-major Professor 
Professor Kevin O’Shea, Co-major Professor 
The widespread use of synthetic drugs and as feed additives has resulted in the 
release of large amounts of biologically active chemicals into the environment. 
Exposure to environmentally relevant concentrations of chemicals can have 
severe effects on human health. Therefore, effective degradation of these 
synthetic, biologically active compounds is of paramount importance.  
Diphenhydramine (DPH) has been selected as a target compound for ultrasound 
remediation. The results demonstrated that ultrasound-induced degradation has 
potential applications in managing aqueous media contaminated with DPH. 
Atorvastatin and roxarsone have been selected as representative substrates for 
chloroperoxidase (CPO) catalyzed transformation of pollutants. These studies 
demonstrate atorvastatin and roxarsone can be degraded efficiently by CPO. The 
vii 
 
transformation products of each compound were identified and the mechanisms 
of CPO catalysis postulated. This study provides a foundation for assessing the 
feasibility of applying CPO in the remediation of water and soil contaminated with 
pharmaceuticals and feed additives. 
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1.1 The occurrence of pharmaceutical pollutants in water 
Pharmaceuticals are manufactured compounds used to treat disease with highly 
specific biological targets. The number of people on prescription drugs continues 
to increase dramatically. The inappropriate disposal of unused and expired 
medicines introduces pharmaceuticals into water systems. Most pharmaceuticals 
are water soluble, and a large number are regularly detected in natural and 
treated water systems, including drinking water supplies worldwide [1, 2]. In 
addition, biologically active compounds have wide spread use for agricultural and 
veterinary purposes and are often used as feed additives. These additives can be 
resistant to metabolism and are persistent in the environment. A further 
complication is the spread of contaminated manure when applied as fertilizer to 
agriculture fields.     
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Sources, pathways, and sinks of pharmaceuticals [3]. 
CHAPTER I. 
INTRODUCTION 
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Selected pharmaceuticals have been detected both in effluent water samples and 
aquatic animal bodies. The concentrations of 56 active pharmaceutical 
compounds were reported in effluent samples across the USA [4]. 
Hydrochlorothiazide was found in every sample, while metoprolol, atenolol, and 
carbamazepine were found in over 90% of the samples. Accumulation of 
fluoxetine and gemfibrozil in fish liver tissue has been reported: Sertraline was 
detected at concentrations as high as 19 and 545 ng/g in fillet and liver, 
respectively [5]. 
 
Pharmaceuticals can have pronounced effects on aquatic and terrestrial 
ecosystems. Laville and his coworkers tested the toxicity of human drugs on fish 
to assess the potential effects of pharmaceuticals in water [6]. Nine 
pharmaceuticals were tested on two fish hepatocyte models. The result showed 
that eight of them were cytotoxic on both cell models with the observed specific 
cell viability inhibition. Furthermore, a wide range of subtle impacts of 
pharmaceuticals has been reported (Table 1.1), including effects on aquatic plants, 
effects on fertility and reproduction in aquatic organisms and impacts on insect 
physiology and behavior [7]. To evaluate the risk to humans, there is a 
considerable lack of information, but the resistance to antibiotics and the 
disruption of endocrine systems could be included. 
 
3 
 
Table 1.1 Reported effects of pharmaceutical compounds on aquatic and terrestrial organisms [7].  
Substrate Medicine class Reported effect 
Erythromycin Antibacterial Inhibition of growth cyanobacteria and aquatic plants  
Tetracycline Antibacterial Inhibition of growth cyanobacteria and aquatic 
plants 
Ibuprofen Anti-inflammatory Stimulation of growth of cyanobacteria and 
inhibition of growth of aquatic plants 
Avermectins Parasiticide Adults insects: loss of water balance, disruption of 
feeding and reduced fat accumulation, delayed 
ovarian development, decreased fecundity and 
impaired mating  
Juvenile insects: delayed development, reduced 
growth rates, development of physical 
abnormalities, impairment of pupariation or 
emergence and a loss of developmental symmetry 
The amount of pharmaceuticals detected from wastewater treatment plant is 
highly dependent on the type of treatment techniques being used [8]. In general, 
conventional water treatment strategies do not effectively remove 
pharmaceuticals [9], thus development of new wastewater treatment methods is 
highly desired.    
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1.2 Treatment to remove pharmaceuticals in water 
Pharmaceuticals can be removed by wastewater treatment process as shown in 
Table 1.2. The removal rates expected for different wastewater treatment 
processes are summarized in table 1.2. As a result of the different chemical and 
physical characteristics of pharmaceuticals, advanced oxidation processes (AOP) 
can achieve higher removal compared than conventional treatment processes. 
Some of the AOPs can achieve 100% transformation of pharmaceuticals for 
specific pollutants.  
Table 1.2 Conventional and advanced wastewater treatment processes and their expected range 
of removal efficiency for pharmaceuticals [10]. 
Wastewater treatment 
Removal range 
(%)
Activated sludge -193-100a
Biological filtration 6-71
Primary settling 3-45
Coagulation, filtration and settling 5-36
Sand filtration 0-99
Ozonation 1-100
Ozonation/ultrasound and sonocatalysis 23-45
Ozonation and catalytic ozonation >9-100
UV irradiation 29
Photolysis (UV/hydrogen peroxide) 52-100
Dark and light Fenton 80-100
UV/TiO2 >95
Biomembrane 23-99
Microfiltration and reverse osmosis 91-100
Reverse osmosis 62-97
Ultrasound 24-100
Conventional wastewater treatment 
Advanced wastewater treatment 
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Advanced techniques to remove pharmaceuticals from wastewater include 
oxidation with ozone [11], filtration by nanofiltration membranes [12] and 
biodegradation with enzymes [13]. While these methods can be effective in the 
degradation of select compounds, they have several limitations, such as overall 
cost, low efficiency, toxic by-products and/or requirements for harsh conditions. 
 
Advanced oxidation processes (AOPs) have been reported as a promising and 
effective methods in eliminating pharmaceutical pollutants [14, 15]. During 
advanced oxidation, hydroxyl radicals (OH·) are generated as the major reactive 
oxygen species (ROS), and capable of destroying different organic compounds in 
water [16, 17]. In aqueous solution, ultrasound of specific frequencies can lead to 
ROS production as shown in Figure1.2. The ROS can destroy a wide variety of  
organic compounds, and thus have great potential as an environmentally friendly 
water treatment technique [18].  
 
Figure 1.2 The generation of reactive oxygen species (ROS) by ultrasound 
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1.3 Ultrasound wastewater treatment 
Ultrasonic water treatment requires sound waves at frequencies greater than 20 
kHz. Figure 1.3 shows the classification of sound determined by their different 
range of frequencies. 
 
Figure 1.3 Approximate frequency ranges corresponding to ultrasound,  
with rough guide of some applications 
Application of ultrasound to contaminated waste water leads to a series of events 
which degrade organic pollutants. Several mechanisms have been proposed to 
explain the ultrasonically induced decomposition process, primarily pyrolysis and 
the production of ROS (OH·, H· and OOH·) mediated processes. The application 
of ultrasound to an aqueous solution results in the formation of gas bubbles 
caused by pressure gradients generated by ultrasound waves passing through 
solution. These bubbles oscillate, in a process called cavitation, and ultimately 
collapse at high temperature and pressure. According to Doulah’s model, the 
energy released by imploding cavitation bubbles in the form of shock waves is an 
important mechanism for the degradation of pollutants [19].  
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Ultrasound has been used to degrade a number of pollutants, such as ethyl 
paraben [20], ibuprofen [21], 5-methylbenzotrizole [22]. Ultrasonication is an  
attractive water treatment technology because it requires no additives can be 
effective on turbid solutions and is safe. Ultrasound can be potentially used in 
remediation of pharmaceutical pollutants alone or as a pretreatment for 
bioremediation process.  
 
1.4 Peroxidase based enzymatic wastewater treatment 
Biodegradation is another water treatment approach in which large molecules are 
converted to small ones or oxidized to less biological active compounds by using 
different types of microorganisms or enzymes. Microorganisms such as bacteria 
and fungi [23, 24], and enzymes such as horseradish peroxidase (HRP) [25] have 
been used in the transformation of organic pollutants in wastewater.  
 
Peroxidases are a large family of redox-enzymes that catalyze the oxidation of a 
substrate by hydrogen peroxide. They function primarily as detoxification 
enzymes, oxidizing non-polar toxins such as pharmaceuticals to produce more 
easily excreted polar compounds. Peroxidases degrade substrates via the 
generation of free radicals, which eventually facilitate bond-cleavage reactions 
[26]. Peroxidase was reported to be efficient in the treatment of phenolic 
contaminants in wastewater treatment [27]. Peroxidases have attracted attention 
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because of their ability to oxidize phenolic and nonphenolic compounds. 
 
Typically, transformation of organic pollutants with peroxidase takes place in three 
steps in the presence of hydrogen peroxide. The first step of the catalytic cycle is 
the reaction between peroxidase and hydrogen peroxide, resulting in a Fe (IV) 
cation radical of the enzyme (compound I). Compound I then reacts with the 
substrate to form a Fe (IV) cation (compound II), which can further react with 
another molecule of the substrate to reset the enzyme. During the reaction, 
pollutant radicals are generated, which undergo degradation by participating in 
reactions with other species (like O2) in solution or reactions with themselves or 
other substrates in solution.  
Figure 1.4 Peroxidase catalytic cycles [28] 
In recent years, many studies have shown that enzyme treatment has several 
advantages over conventional methods, since it is environmentally friendly, cost 
effective and ease to handle. Furthermore, enzymatic transformation of organic 
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pollutants can occur under relatively harsh conditions such as high salinity, low pH, 
and extreme pollutant concentrations. More importantly, the high specificity of 
enzymes enables the pollutants to be degraded efficiently in the presence of 
natural organic matter present in many drinking water sources [29]. The most 
commonly used peroxidases in pollutants degradation are chloroperoxidase 
(CPO), horseradish peroxidase (HRP), lignin peroxidase (LiP), manganese 
peroxidase (MnP), and lactoperoxidase (LPO). In this study, CPO will used to 
catalyze the transformation of selected organic pollutants.  
 
1.5 Properties of chloroperoxidase 
Chloroperoxidase is one of the most versatile enzymes in heme-containing family 
with one ferriprotoporphyrin IX prothetic group contained per enzyme molecule. 
Chloroperoxidase, a heme-thiolate protein, was isolated and characterized by 
Hager and his coworkers in 1966 [30] from the marine fungus Caldariomyces 
fumago (C. fumago). Chloroperoxidase is heavily glycosylated (25-30% 
carbonhydrates, two high-mannose N-glycosylation sites) with a molecular weight 
of approximately 42,000 Daltons [31].  
 
The capacity of CPO to perform diverse reactions makes it one of the most 
versatile enzyme in heme-containing family. Chloroperoxidase catalyzes the 
classical peroxidation reactions as well as P-450 like reactions, which include 
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halogenation, hydroxylation, peroxidation and epoxidation [32]. When catalyzing 
these reactions, CPO does not need cofactors but requires hydrogen peroxide 
(H2O2) or tert-butyl hydroperoxide (t-BuOOH) as electron acceptors. 
Chloroperoxidase has been found in the ascomycete Emericella nidulans and the 
basidiomycete Agaricus bisporus [33]. Chloroperoxidase is a highly hydrophilic 
enzyme which makes it easy to dissolve in water. On the basis of all these 
characteristics, CPO has been considered a promising candidate in wastewater 
treatment applications. 
 
1.6 Structure of chloroperoxidase 
Despite functional similarities with other heme peroxidases, CPO has quite a 
different overall folding compared to most classical peroxidases. 
Chloroperoxidase folds into a tertiary structure consists of eight helical segments 
shown in different colors in figure 1.5 [34].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Crystal structure of CPO [34] 
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The heme porphyrin ring is shown in red. Unlike other heme peroxidases that use 
histidine as the proximal heme iron ligand, the proximal heme ligand in CPO 
derives from the sulfur atom of a cysteine residue (like P450). Unlike P450 that 
uses mainly non-polar groups as oxygen binding site in the distal pocket, the 
substrate-binding site in CPO is formed primarily with polar amino acids [35, 36]. 
Hence, CPO is thought to have an active site hybridized from those of P450s and 
peroxidases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Stereoview of the CPO active site. Hydrogen bonds involving the distal side water 
molecule, Glu183 (the proposed acid–base catalyst) and His105 are shown as dashed lines.  
The histidine is only 3.5 å from the heme propionate that binds a cation [37]. 
In the distal pocket of CPO, the acid-base catalytic group is glutamic acid instead 
of histidine find in most traditional heme peroxidases. Glutamic acid 183 can form 
hydrogen bond with His 105 (only 3.5 Å away from the heme propionate) and 
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function as a general acid-base catalyst. In Figure 1.6, the side chain of Glu 183 
extends out from the distal helix to the position close to the peroxide binding site. 
Furthermore, the hydrogen bound between His 105 and Glu 183 facilitates the 
cleavage of heme bound O-O in the formation of compound I complex. Two 
pheylalanine residues ( Phe 103 and Phe 186) stay close to the heme center that 
serves as the gate keeper in controlling substrates access to the heme active site. 
 
1.7 Substrate-binding pocket  
 
Figure 1.7 Slice through a surface representation of CPO (including sugars attached to the 
protein). The two channels leading to the active site are marked by arrows, and the heme is shown 
in magenta. The halide binding site 2 (yellow sphere, bromide; blue, iodide) is located within the 
narrow channel and the iodide specific binding site 3 at the end of the channel implicating a 
pathway for halide access from the surface (site 1) to the heme though this narrow channel. [38] 
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Unlike other peroxidases whose heme edge is available for substrate access, a 
substrate binding pocket is required for CPO to hold the substrate in place. There 
are two channels for substrate to enter the heme active center of CPO from the 
enzyme surface, the narrow channel and the wide channel [38]. Most halide 
binding sites are located in the narrow channel, which indicates it is the major 
channel for halide ions to access the active oxoferryl center. The narrow channel 
is mostly hydrophobic near the heme center but more polar and further away from 
the center (Figure 1.7), which could hold the substrate in place for stereospecific 
transformations.   
 
1.8 Mechanism of CPO catalyzed reactions 
The unique structure of CPO allows it to have multiple functions in catalyzing a 
variety of reactions. Chloroperoxidase was found to follow the catalytic cycle of a 
heme-thiolate haloperoxidase as shown in Figure 1.8. The catalytic cycle is 
initiated by the heterolytic cleavage of the O-O bond in H2O2 by transferring two 
electrons from the heme center. During the reaction, water and an oxo-ferryl 
cation radical intermediate (compound I) are generated. Compound I is an active 
intermediate and is involved in different types of chemical reactions. In one 
pathway, compound I reacts with the substrate (RH) to form an oxoiron (IV) unit 
(compound II). Then compound II can either be reduced back to the resting state 
of the enzyme or undergo the classic peroxidase pathway. 
14 
 
 
Figure 1.8 Catalytic cycle of a heme-thiolate  
(1) Resting ferric enzyme, (2) compound I, (3) compound X that releases hypohalous acid (HOX), 
(4) protonated compound II, (5) compound II. Classic peroxidase reaction (e.g., phenol oxidation): 
(2) ⇒ (4) ⇒ (5) ⇒ (1) (without oxygen transfer to the substrate); halogenation: (3) ⇒ (1); 
hydroxylation (e.g. OH-transfer to benzylic carbon, see also Fig. 3: (4) ⇒ (1); oxygenation (e.g. 
sulfoxidation): (5) ⇒ (1) (oxygen transfer to the substrate [39] 
Compound I can also capture halide ion (X-) to give a hypochlorite adduct Fe-OX 
(compound X). Compound X is unstable and can be protonated in acidic 
environment. Eventually a hypohalous acid (HOX) forms and subsequently can 
react with available organic substrates susceptible to electrophilic attack. Whether 
the HOX is released to the solution or remains associated with COP remains 
controversial [40, 41], but recent reports that describe the reaction between 
chlorine and different substrates indicates that HOX diffuses into the solution 
instead of binding to the active site [42]. 
15 
 
1.9 Reactions catalyzed by chloroperoxidase 
Chloroperoxidase can catalyze a variety of reactions which include halogenation, 
hydroxylation and many types of oxidation reactions. Halogenation by CPO 
usually happens in solution at pH less than 3. Substrates susceptible to 
halogenation include a variety of structures, such as polycyclic aromatic 
hydrocarbons [43] and flavonoids [44]. 
 
Figure 1.9 Chlorinated products from the enzymatic halogenation of aromatic compounds by 
chloroperoxidase in the presence of hydrogen peroxide and chloride ions. [43] 
 
Figure 1.10 Enzymatic halogenation of flavones [44] 
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Efficient hydroxylation of organic substrates has also been achieved with this 
peroxidase. Chloroperoxidase is able to catalyze the hydroxylation of 
1,2-dihydronaphthalene with t-butyl hydroperoxide as oxidant [45], the 
hydroxylation of the furan ring with hydrogen peroxide as an O2 donor [46]. All of 
these are halide-dependent reactions and require the participation of halide ions. 
 
 
Figure 1.11 Chloroperoxidase-catalyzed oxidation of 1,2-dihydronaphthalene [45]. 
 
 
Figure 1.12 Chloroperoxidase-catalyzed oxidation of the furan ring [46]. 
 
Besides halogenation and hydroxylation, CPO is able to catalyze a number of 
oxidations independent of halide ions including oxidation of the amino group [47], 
enantioselective sulfoxidation of thioanisole [33] and N-dealkylation [48], etc.  
17 
 
 
Figure 1.13 Selected nonhalogenating oxidations catalyzed by CPO. 1 demethylation of 
N,N-dimethylaniline; 2 oxidation of the amino group of chloroaniline into the corresponding nitroso 
compound; 3 enantioselective sulfoxidation of thioanisole into the corresponding (R)-sulfoxide [33, 
47, 48]. 
 
The goal of this study is to examine the potential effectiveness of ultrasound and 
CPO-based enzymatic degradation for the removal of selected pollutants in water. 
Detailed kinetic study and product analysis have been carried out to better 
understand the transformation process. The kinetic study help for modeling 
treatment for real applications. Based on the products identified, the mechanisms 
of the transformation are postulated.  
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2.1 Background 
Diphenhydramine (DPH), also known as Benadryl, is a member of the 
ethanolamine-based antihistamine family. It is one of the first antihistaminic 
agents and was discovered in 1946. The main use of diphenhydramine is to treat 
allergies. Diphenhydramine was the most commonly used antihistamine in 2007 
[49]. Topical use of diphenhydramine to relieve itching is also common, including 
as sprays and lotions. Diphenhydramine has been detected in water and in 
shellfish bodies. The bioaccumulation factor for diphenhydramine is 118-218 in 
marine shellfish [50], which has the potential to be transferred to humans through 
marine food webs. Therefore, there is an urgent need to find an effective method 
to remove DPH from natural water bodies and drinking water sources. 
Figure 2.1 Chemical structure of Diphenhydramine (DPH) 
The aim of this project is to investigate the potential application of ultrasound in 
the degradation of DPH. Degradation efficiency and detailed kinetics studies were 
conducted to assess the effectiveness of ultrasound for degradation of DPH in 
aqueous media. 
CHAPTER II. 
ULTRASOUND ASSISTED TRANSFORMATION OF DIPHENHYDRAMINE 
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2.2 Materials and methods 
2.2.1 Materials 
The DPH standard was in the form of diphenhydramine hydrochloride (10 g) and 
was purchased from MP Biomedicals, LLC. The HPLC grade acetonitrile was 
purchased from Fisher Scientific. All reagents were used as received. All aqueous 
solutions were prepared with Millipore filtered water and volumetric lab 
equipment. 
 
2.2.2 Sample preparation 
An ultrasonic generator equipped with a 500 ml reaction vessel was used to 
conduct the study. All solutions were prepared in a 500 ml volumetric flask using 
Millipore filtered water. The mixture was then transferred to the ultrasonic vessel. 
The frequency, pulse, amplitude and repetition of the generator were all set in the 
medium value. The solution was gently purged with O2 for 15 min and rubber 
septum was used to seal the vessel. The reaction vessel was placed in a tank 
filled with ice water to maintain a temperature around 10 °C. A 10 ml syringe was 
filled with oxygen and inserted into the vessel to replace the solution being 
collected for sampling. The syringe was rinsed with deionized water between 
sample collections. Samples were collected at different treatment times for HPLC 
analysis. 
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2.2.3 HPLC Analysis 
The concentration of DPH was monitored by a Varian ProStar HPLC, equipped 
with a ProStar 410 autosampler and a ProStar 335 photodiode array detector 
under the following conditions: a reversed phase C18 column (5µl, 250 × 4.6 mm) 
with a constant solvent ratio of A: B 60:40. Solvent A was 20 mM NaH2PO4 
acidified to pH 2.84 using H3PO4. (pH might be lower to avoid trailing to get a 
better peak shape.) Solvent B was acetonitrile. A volume of 30μl sample was 
injected and a flow rate of 1ml/min was used for elution. The detection wavelength 
was set at 216 nm. 
 
 
 
 
 
 
 
 
 
 
21 
 
2.3 Results and discussion 
2.3.1 Transformation of DPH as a function of concentration 
 
Figure 2.2 Effect of concentration on ultrasound degradation of DPH   
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The ultrasonically induced degradation was monitored at different initial 
concentrations varying from 4.6 to 72.5 μM (Figure 2.2). The concentration was 
plotted as a function of treatment time and the data fit to the best line with the 
slope representing the observed degradation rate. The results demonstrate 
ultrasound was effective for the degradation of DPH over different concentrations. 
To minimize the effect of by-products only the first 10-20% degradation was 
considered in measuring the initial degradation rate. The observed initial rates are 
0.386 μM • min-1 for 4.6 μM, 0.587 μM • min-1 for 6.2 μM, 0.815 μM • min-1 for 18.5 
μM, 0.999 μM • min-1 for 40.1 μM, 1.171 μM • min-1 for 56.0 μM, 1.461 μM • min-1 
for 72.5 μM (Table 2.1). Based on these results, the initial rate incresed as the 
concentration increased,  which can be explanied by the existence of more DPH 
molecules at high concentration to be degradated by the steady state of ROS 
generated or decomposed by pyrolysis. 
Table 2.1 Initial rate under different concentrations 
C (μM) R (μM • min-1) 
4.6 0.386 
6.2 0.587 
18.5 0.815 
40.1 0.999 
56.0 1.171 
72.5 1.461 
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The degradation of different concentrations of DPH as a function of time is 
illustrated in Figure 2.3. The plot of DPH removal, [DPH] / [DPH]0 as a function of 
time shows less time in the removal of DPH at low concentration (4.6 μM and 6.2 
μM). As concentration increases (56 μM and 72.5 μM), the removal efficiency 
decreased.  
Figure 2.3 Removal of DPH during ultrasound treatment 
Ultrasound leads to production of steady state concentration of ROS which will 
have a pronounced effect on overall degradation of the target compound. 
Therefore, when there is an excess number of DPH molecules, it is logical 
treatment times need to increase to generate more ROS to achieve complete 
degradation. 
[DPH] (μM) 
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2.3.2 Kinetic studies 
Evaluation of reaction kinetics can provide useful mechanistic information and 
important parameters for the assessment and modeling of ultrasound treatment. 
First order reaction and Langmuir-Hinshelwood kinetic model were applied to 
provide insight about the degradation process. 
Pseudo-first-order 
In previous studies, it was shown that ultrasonic assisted degradation follows the 
first order kinetics as shown below: 
In(
Ct
C0
) = −kt 
Where Ct is the concentration (at time t) and C0 is the initial concentration (at time 
0), and k is the first-order rate constant (min-1). The first order rate constant k can 
be extracted from the slope of plot ln (Ct/C0) as a function of reaction time.
 
Figure 2.4 First-order plot under different DPH concentrations 
[DPH] (μM) 
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The observed first-order rate constants are 0.133 min-1 for 4.6 μM, 0.147 min-1 for 
6.2 μM, 0.061 min-1 for 18.5 μM, 0.029 min-1 for 40.1 μM, 0.025 min-1 for 56.0 μM, 
0.025 min-1 for 72.5 μM (Table 2.2). The rate constant becomes constant as the 
concentration of DPH > 40μM), which indicates that the reaction system becomes 
saturated.   
Table 2.2 Pseudo-first-order rate constants under different concentrations 
[DPH] (μM) k 
4.6 0.133 
6.2 0.147 
18.5 0.061 
40.1 0.029 
56.0 0.025 
72.5 0.025 
 
Langmuir- Hinshelwood 
Further analysis of the degradation process was achieved by employing kinetic 
models for interfacial process. Since the degradation process is heterogeneous, 
and can occur at the gas-liquid interface (at surface of cavitation bubble), the 
Langmuir-Hinshelwood kinetic model can be applied to provide insight about the 
degradation on localized substrate due to pyrolysis and degradation reactions 
from reactive oxygen species at the interface.  
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The form of the Langmuir-Hinshelwood model is given as: 
 
Where r0 is initial rate, C0 is the initial concentration of substrate. The value kr is 
the reactivity coefficient, and K is the equilibrium constant.  
 
C0 1/C0 r0 1/r0 
4.6 0.217 0.386 2.591 
6.2 0.161 0.587 1.704 
18.5 0.054 0.815 1.227 
40.1 0.025 0.999 1.001 
56.0 0.018 1.171 0.854 
72.5 0.014 1.461 0.684 
 
 
 
 
 
 
 
 
Figure 2.5 Langmuir- Hinshelwood plot of ultrasound treatment of DPH. The insert table is the 
initial rate at different concentrations of DPH and the inverse of them. 
The Langmuir-Hinshelwood kinetic parameters K and kr were determined by the 
slope and intercept of plot 1/r0 as a function of 1/C0 (Figure 2.5), which yields K = 
0.02 L/μM and Kr = 1.4 μM/min·L under our experimental conditions. The kinetic 
parameters obtained provide insight about both surface adsorption and oxidative 
reactivity. 
rr kKCkr
111
00

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2.4 Conclusion 
During ultrasonic cavitation, three zones are generated: hot spot, gas-liquid 
interface and bulk solution. The hot spot possesses extremely high pressure (100 
atm) and temperature (5000K), which will decompose H2O and O2 to produce 
reactive oxygen species (ROS). Reactive oxygen species play distinguishable 
roles in the degradation process. Once generated, ROS can diffuse to the 
interface and bulk solution which contains organic pollutants, subsequently 
leading to oxidative degradation of DPH.  
 
Our study demonstrated that DPH was effectively degraded under ultrasound 
treatment, and the concentration of DPH was critical and correlated to the initial 
rate constant during treatment. The process was most effective under relatively 
low concentrations, at which DPH could be degraded by 50% in the first 5 min. 
The degradation process followed pseudo-first-order kinetics. The first-order rate 
constants were determined in the presence of different concentrations of DPH. 
The rate constants decrease as the concentrations of DPH increase and level off 
as the DPH reaches > 40μM, which indicates that the reaction system is subject 
to saturation kinetics at higher concentrations. Finally, the Langmuir-Hinshelwood 
kinetic model was successfully applied and the parameters obtained (K=0.02 
L/μM and Kr=1.4 μM/min·L) can provide insight about the degradation process at 
the gas-liquid surface. 
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Our study leads to a better fundamental understanding of ultrasound induced 
degradation of DPH, which demonstrated that ultrasound-induced degradation 
has great potential to serve as an effective method for treatment of aqueous 
media contaminated with DPH. Furthermore, the first order kinetic study provided 
in depth knowledge about the ultrasound assisted degradation, which can also 
help to predict the required reaction time to reach the treatment objective. The 
Langmuir-Hinshelwood kinetic model provide insight about the localization of DPH 
at the interface as well as the subsequent reactivity, which are critical in assessing 
practical water treatment technologies. 
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3.1 Background 
Atorvastatin (ATV), also known as Lipitor (Figure 3.1), is one of the most 
commonly prescribed drugs in the US and Europe [51]. It inhibits the activity of 
hydroxymethylglutaryl-CoA (HMG-COA) involved in cholesterol biosynthesis, thus 
blocks the production of cholesterol. Atorvastatin has a molecular formula of 
C66H68CaF2N4O10 with a molecular weight of 1155.34 g/mol. It is a white 
crystalline powder with a dissociation constant (pKa) of 4.46.  
  Figure 3.1 Chemical structure of ATV 
The discovery of statins was a breakthrough in the prevention of 
hypercholesterolemia and related diseases. From 2002 to 2009, atorvastatin 
became the world’s best-selling drug, with more than 9.3 billion dollars in sales 
during that time. The presence of ATV in sewage efﬂuents and surface waters has 
been observed at concentrations of mg/L levels [52]. Moreover, it has been 
detected in many water samples including treated sewage samples. When 
present to aquatic environments, ATV could be harmful to the aquatic ecosystem, 
adversely affecting aquatic organisms.  
CHAPTER III. 
CPO CATALYZED TRANSFORMATION OF ATORVASTATIN 
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The aim of this project was to investigate the potential application of CPO in the 
degradation of ATV. The rate of CPO in the degradation of ATV was measured. 
The CPO transformation of ATV was run at a range of Cl- and Br- concentrations, 
at buffered pH, and over a range of concentrations of H2O2. The enzyme kinetics 
and degradation pathway were studied under the optimized conditions. 
 
3.2 Materials and methods 
3.2.1 Materials 
Chloroperoxidase (CPO) was isolated and purified from Caldariomyces fumago 
according to the protocol reported by Morris and Hager [31]. Chloroperoxidase 
with Reinheitszahl value (Rz, purity index of heme enzymes) of 1.3 or higher was 
used for all experiments. The concentration of CPO was determined by 
measuring the absorbance at 398 nm using a molar extinction coefficient of 
91,200 M−1cm−1 [31]. 
 
Atorvastatin was purchased from AK Scientific (Union City, CA, USA). All solvents 
used were purchased from Thermo Fisher Scientific Inc. (Waltham, MA, USA) and 
were of HPLC grade or Optima® LC/MS grade. Millipore Milli-Q water (18.2 MΩ) 
was used throughout. 
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3.2.2 Sample preparation 
The reaction was conducted in a buffer solution with 100 mM KH2PO4 and 20 mM 
KBr at pH 3.5. Atorvastatin was dissolved in methanol as the stock solution. H2O2 
stock was prepared by diluting 35% concentrated H2O2 solution with buffer. Drug 
stock was added into the buffer solution to get a sufficient mix. The CPO stock 
solution was then added as a catalyst of the reaction. The H2O2 stock solution was 
subsequently added to initiate the reaction. Upon completion of the reaction, ethyl 
acetate was used to extract the filtrate and quench the reaction. The metabolites 
were extracted into the top organic layer during the liquid-liquid extraction while 
the CPO and salt in buffer remained in the aqueous layer. The top organic layer 
was separated and nitrogen gas was used to evaporate the organic solvent. The 
residues containing metabolites were then dissolved in different solvents for 
instrumental analysis. All samples were stored at 4 °C before measurements. 
 
3.2.3 UV-Visible spectrophotometry 
A VARIAN UV-Vis spectrophotometer (Cary 200 Bio) was used to record the 
optical data. The full scan mode was used to monitor the real-time absorbance 
change as a function of time. Using the spectra obtained under the full scan 
mode, the transformation from the reactant to products was observed. The kinetic 
parameters of the reaction were extracted by monitoring the absorbance change 
at a selected wavelength (241 nm for ATV) as a function of time.  
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3.2.4 UPLC-MS spectrophotometry 
Agilent 1290 Infinity UPLC system coupled with an orthogonal geometry 
Electrospray Ionization (ESI) equipped Agilent 6530 Q-TOF mass spectrometer 
was used for the separation and identification of the metabolites. An Agilent 
ZORBAX Eclipse plus C18 Rapid Resolution High Definition (RRHD) column (3.0 
×100 mm, 1.8 µm) was applied, the column temperature was set at 30 °C. An 
infinity 1290 automatic injector was used to inject 1 µL of the sample to the 
column. A flow rate of 0.4 mL/min was used and an aqueous mobile phase A 
consisting 5 mM ammonium formate with 0.1% formic acid and the organic mobile 
phase B consisting of 90% acetonitrile and 10% water with 0.1% formic acid. The 
optimized chromatographic gradient was at 0 minute, 50% A and 50% B and B 
increased linearly to 95% over 6 minutes, this gradient was maintained for 4 
minutes. Scanning was performed from m/z 100 to 1000 in the positive ion mode. 
The accurate mass of the molecular ions was processed using the Agilent 
MassHunter Qualitative Analysis software.  
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3.3 Results and discussion  
3.3.1 Transformation of ATV by CPO 
The transformation of ATV catalyzed by CPO is monitored by UV-vis optical 
spectrophotometry. Atorvastatin showed a strong absorption at 241 nm as shown 
in Figure 3.2. The spectra of ATV with only H2O2 or CPO shows similar spectral 
features to ATV, indicating that no reaction occurs. However, the spectra of 
solution of ATV after addition of H2O2 or CPO shows a distinct decrease in 241 nm 
and a concomitant increase in 341 nm. The change of the spectral clearly showed 
the transformation of ATV. Control groups of only CPO and H2O2 were also 
conducted to exclude the absorbance change caused by the addition of H2O2 and 
CPO. 
 
Figure 3.2 Transformation of ATV by CPO. ATV=8.66 µM, CPO=4.8 nM, H2O2= 0.5mM 
Phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH 3.5 
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The CPO-induced transformations of ATV at different time points are shown in 
Figure 3.3. The spectra was collected at 0, 40, 80, 120, 160 and 200 sec after the 
reaction, including 25 sec to collect data for full spectrum. The ATV spectra as a 
function of treatment time show an incremental decrease at 240 nm, with the 
growth of a band at 341 nm. Interestingly, an isosbestic point was observed 
around 300 nm. This point indicated that at λ=300 nm, the UV absorbance of ATV 
and the generated products remained constant throughout the whole reaction. 
The conversion from the reactant to the product(s) is clearly indicated in the graph, 
providing fundamental information for further kinetic studies and product 
identification. The reaction rate decreases gradually reflected by the relative 
change in absorbance with time. 
 
Figure 3.3 Transformation of ATV by CPO at different times. ATV=8.66 µM, CPO=4.8 nM, 
H2O2= 0.5mM Phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH 3.5 
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3.3.2 The effect of pH 
The effect of pH was investigated to determine the optimal pH for CPO catalyzed 
ATV transformation (Figure 3.4).  
Figure 3.4 The effect of pH on ATV transformation 
ATV=8.66 µM, CPO=4.8 nM, H2O2= 0.5mM Phosphate buffer: 100 mM K2HPO4, 20 mM KBr, 
pH 2.5, 3, 3.5, 4, 4.5 and 5 respectively. Monitored by UV at λ=241nm 
The experiment was conducted in the pH range of 2.5-5.0. In the presence of 20 
mM Br-, the optimum pH for the transformation of ATV is 3.5. The transformation 
rate of ATV increased significantly with increasing pH, and reached a maximum 
around pH 3.5. The degradation efficiency decreased sharply at pH > 3.5. This 
change indicated the transformation of ATV was a pH-dependent process, which 
could be attributed to the change in the protonation state of the ionizable group in 
compound X of CPO. Compound X was reported to be involved in most CPO 
catalyzed halide dependent reactions [53], and releases the powerful oxidizing 
agent (HXO) under acidic conditions. 
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3.3.3 The effect of hydrogen peroxide concentration 
To determine the optium concentration of hydrogen peroxide, the experiment was 
carried out in the presence of varying concentrations of H2O2 (Figure 3.5). 
Figure 3.5 The effect of H2O2 concentration on ATV transformation 
ATV=8.66 µM, CPO=4.8 nM, phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH=3.5, 
H2O2= 0, 0.35, 1.06, 2.11, 3.17, 4.22 and 5.28 mM respectively. Monitored by UV at λ=241nm 
Control reaction showed the addition of H2O2 is required, and rate of 
transformation increased as the concentration of H2O2 increased up to 2 mM. The 
H2O2 concentrations above 2 mm decreased the transformation rate. One 
possible explanation is that excess H2O2 deactivates or degrades the enzyme. 
High concentrations of H2O2  have been reported to destroy the porphyrin 
prosthetic group in most heme containing enzymes [54]. Excess H2O2 may also 
inhibit the enzymatic process because of competition with halide ions required for 
the formation of compound X. A low concentration of H2O2 was applied for CPO 
induced transformation of ATV. 
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3.3.4 The effect of halide ions 
Since many of the reactions catalyzed by CPO are either dependent upon or 
accelerated by halide ions [55], it is vital to understand the effect of chloride (Cl-) 
and bromide (Br-) ions. Figure 3.6 shows the relationship between the rate of ATV 
degradation and the ratio of Cl- or Br- to ATV. 
Figure 3.6 The effect of halide ions on ATV transformation 
ATV=15 µM, KBr=1.5, 4.5, 7.5, 12 and 15 µM respectively, KCl=0.15, 0.3, 0.75, 1.05, 1.35 and 1.5 
mM respectively, CPO=2.4 nM, H2O2=15.5 µM Monitored by UV at 241nm 
There was no transformation observed without Cl- and Br-. Moreover, the 
transformation rate was proportional to the ion to drug ratio in a certain range 
(From 0.1-1 for Br- and 0.7-6.7 for Cl-). The transformation rate in the presence of 
Br- was more efficient when compared to Cl-. This could be attribute to the efficient 
distinction in the production of HBrO and HClO or their ability to oxidize ATV within 
CPO environment.  
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3.3.5 Product identification 
I used HPLC-MS to identify the products from CPO-catalyzed ATV transformation. 
The results are shown below. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 The chromatogram and MS spectra of ATV 
Retention time (min) 
Mass to charge ratio (m/z) 
Retention time (min) 
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Figure 3.8 The chromatogram and MS spectra of metabolites  
 
Mass to charge ratio (m/z) 
Mass to charge ratio (m/z) 
Mass to charge ratio (m/z) 
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From the chromatogram obtained, we can see there are three major peaks 
showing different retention times, suggesting the formation of putative products. 
When extracting the mass spectra from the middle peak (5.5 min), it shows a 
co-elution of two different substances, ATV at m/z 559 and one of the metabolites 
at m/z 557. The peak at 4.9 min was giving an ion at m/z 575, which indicates the 
hydroxylation of aromatic rings to the parent compound. The peak eluted at 5.9 
min shows a molecular ion [M+H]+ at m/z 557, which has the same m/z ratio as 
the peak eluted at 5.5 min. This result indicated that there were two lactone 
isomers formed based on the OH substituted structure. Based on these 
observations, four metabolites from CPO catalyzed ATV transformation are 
proposed as listed in Table 3.1. 
Table 3.1 Accurate-Mass LC-Q-TOF-MS data for the identification of ATV and its metabolites. 
Name Formula Rentention time 
(min) 
Experimental 
mass (m/z) 
Theoretical 
mass (m/z) 
ATV C33H35FN2O5 5.589 559.2661 558.2530 
o-OH-ATV C33H35FN2O6 4.937 575.2551 574.2479 
p-OH-ATV C33H35FN2O6 4.937 575.2551 574.2479 
o-OH-ATV-lactone C33H33FN2O5 5.553 557.2391 556.2374 
p-OH-ATV-lactone C33H33FN2O5 5.935 557.2464 556.2374 
The theoretical mass to charge ratios were calculated for ATV and its metabolites 
as a reference to their experimental values. These products were confirmed by 
different retention times and accurate mass-to-charge ratios. For hydroxylated 
metabolites, the isomer’s peak were detected at the same retention time, while for 
hydroxylated lactone metabolites the retention times were different.   
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3.3.6 Mechanism of CPO-catalyzed ATV transformation 
On the basis of LC-MS and UV-Vis spectroscopic studies, the mechanism of 
CPO-catalyzed transformation of ATV is proposed (Figure 3.9). 
 
Figure 3.9 Proposed mechanism of ATV transformation (C=Cl- or Br-) 
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3.4 Conclusion  
In summary, we found that CPO readily transformed ATV over a range of acidic 
solutions (2.5 to 5) with the fastest transformation observed at pH=3.5. A range of 
[H2O2] was tested and the maximum rate was achieved when H2O2 concentration 
reached 2.11 mM. However, further addition of H2O2 repressed the transformation 
possibility because of deactivation of the enzyme caused by high concentration of 
H2O2. The important role halide ion played in CPO catalyzed transformation of 
ATV was demonstrated; although, no halogenated products are identified. 
Bromide ion was shown to be more potent in CPO catalyzed transformation of 
ATV than chloride ion, which could be attributed to the different binding affinity of 
Cl- or Br- to CPO. 
 
The LC-MS analysis proved to be an efficient technique for determining the 
metabolites of ATV. My result is in good agreement with the reported mechanism 
of ATV transformation [56]. Atorvastatin and its major hydroxylated metabolites, 
2-ATV and 4-ATV, are present in equilibrium with their corresponding inactive 
lactone forms. The mechanism proposed includes the formation of an oxoferryl 
π-cation radical intermediate (compound I), and a hypohalite adduct (compound 
X). The pH dependent experiment suggests the protonation of compound X under 
acidic conditions, which can release HOX from the active site and subsequently 
reacts with ATV to initiate an electrophilic attack.  
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The study provided a fundamental understanding of enzymatic based 
transformation of ATV. The effect of halide ion and pH helps our understanding of 
how environmental factors would affect the degradation in real application. 
Identification of products shed light into understanding of the characteristic of 
CPO-catalyzed reactions. Based on the proposed degradation pathway, the 
associated toxicity of intermediates/products can be studied to assess their 
impact on environment. These studies provided in depth knowledge about the 
enzymatic degradation, which are critical for environmental friendly water 
treatment technologies.  
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4.1 Background 
Roxarsone (ROX), 4-hydorxy-3-nitrobenzenearsenic acid (Figure 4.1), is used as 
a common feed additive in poultry industry. It is a derivative of phenylarsonic acid 
as it has an arsenic directly linked to a benzene ring. Roxarsone is used to 
improve feed efficiency and increase weight gain in chicken and pigs. Figure 4.2 
shows how ROX is introduced into the environment. Roxarsone is a threat to 
humans since arsenic species has been recognized as a toxic metalloid 
presented in rivers [57] with a high solubility in water.  
Figure 4.1 Chemical structure of Roxarsone (ROX)  
Figure 4.2 Fate of ROX used as feed additives [58] 
CHAPTER IV. 
CPO CATALYZED TRANSFORMATION OF ROXARSONE 
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Studies have shown that arsenic is readily released to surface and ground water 
from poultry litter [58], leading to a serious ROX pollution problem. With the 
development of nanotechnology, the adsorption of ROX in aqueous solution was 
investigated [59], however, this technique has limitations for drinking water. AOPs 
have been used in the treatment of organoarsenicals like ROX [60, 61]. Hydroxyl 
radical mediated processes lead to the degradation of ROX however the 
non-selective nature of OH· is a problem for practical applications. Furthermore, 
advanced oxidation treatment drives transformation of organoarsenicals to 
inorganic forms As (V) which requires removal to prevent arsenic presence in 
discharged agricultural wastewater. 
 
The goal of this study was to examine the potential effectiveness of CPO-based 
enzymatic transformation for the removal of ROX. The solution pH, the 
concentration of halide ion and the concentration of H2O2 were varied to identify 
optimal conditions. Detailed kinetic and product studies were carried out under 
optimal conditions. The major-products were identified, and the mechanism of 
ROX transformation was proposed. 
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4.2 Materials and methods 
4.2.1 Materials 
Chloroperoxidase (CPO) was isolated and purified from Caldariomyces fumago 
according to the protocol reported by Morris and Hager [31]. CPO with Rz of 1.3 
or higher was used for all experiments. The concentration of CPO was 
determined by measuring the absorbance at 398 nm using a molar extinction 
coefficient of 91,200 M−1cm−1 [56]. 
 
Roxarsone was purchased from Tokyo Kasei Kogyo Co., Ltd, (Tokyo, Japan). All 
other chemicals and solvents were purchased from Thermo Fisher Scientific 
(Waltham, MA, USA) and are of either reagent or analytical grade. All aqueous 
solutions were prepared with Millipore filtered water (18.2 MΩ) and volumetric lab 
equipment. 
 
4.2.2 Sample preparation 
The reaction was conducted in 100 mM KH2PO4 buffer containing 20 mM KBr at 
pH 3.5. Roxarsone was dissolved in buffer as the stock solution. H2O2 stock was 
prepared by diluting 35% concentrated H2O2 solution into the buffer solution. 
Roxarsone stock was added into the buffer solution and mixed thoroughly. The 
CPO stock solution was then added as a catalyst of the reaction. The H2O2 stock 
solution was subsequently added to initiate the reaction. Upon completion of the 
reaction, ethyl acetate was used to extract the products and quench the reaction. 
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During extraction, the metabolites were extracted into the top organic layer during 
the liquid-liquid extraction while CPO and salt remained in the bottom aqueous 
layer. The top organic layer was separated and nitrogen gas was used to 
evaporate the solvent. The residues containing metabolites were dissolved in 
different solvents for instrumental analysis. Samples were stored at 4 °C before 
use. 
 
4.2.3 UV-Visible spectrophotometry 
A VARIAN UV-Vis spectrophotometer (Cary 200 Bio) was used to monitor the 
progress of the reaction. The full scan mode was used to monitor the real-time 
absorbance change as a function of time. Based on the spectra obtained under 
the full scan mode, the conversion of the reactant to products was observed. To 
determine the rate of ROX degradation, the kinetic mode was used to monitor the 
absorbance change at a selected wavelength (223 nm for ROX) as a function of 
time. The rate was calculated according to the equation below: 
 
Rate(µM 𝑚𝑖𝑛⁄ ) =
𝐴0 − 𝐴𝑡
0.1087 × (𝑡0 − 𝑡𝑡)
 
 
A0 is the absorbance monitored at time t0, At is the absorbance monitored at time 
tt, and 0.1087 (µM-1 cm-1) is the measured extinction coefficient of ROX at 223 
nm. 
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4.2.4 NMR characterization 
Nuclear magnetic resonance (NMR) spectroscopy were employed to identify the 
major transformation products. The NMR experiments were carried out on a 
Bruker 400 MHz NMR spectrometer operating at a proton frequency of 400.13 
MHz. The samples were all dissolved in deuterated solvents before transferring to 
5 mm NMR tubes. All spectra were recorded at 298 K using standard pulse 
programs from the manufacturer. 
 
4.2.5 Mass Spectrometry 
A volume of 100 L of the sample was mixed with 10 L of Agilent ESI tuning 
solution (p/n G2421-60001; L/N A117489) and 890 L of acetonitrile, for a final 
concentration of 1 mg/L. A blank was prepared similarly, using 100 L of acetone 
(OptimaTM grade) instead of the sample. Using a syringe pump (3 μL/min), the 
obtained solution was infused into the Turbo VTM ESI source of an AB SCIEX 
QTRAP 5500® triple quadrupole mass spectrometer operating in full scan 
(100-650 Da) in negative mode. Product ion scan (Target→50-300 Da) was 
performed at medium collision gas pressure and at 40 eV of collision energy. 
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4.3 Results and discussion  
4.3.1 Transformation of ROX by CPO 
The transformation of ATV catalyzed by CPO is shown in Figure 4.3. Roxarsone 
showed a strong absorption at 223 nm. With the addition of only H2O2 or CPO, the 
spectral pattern remains essentially unchanged, indicating no reaction occurs. 
When H2O2 and CPO were mixed together with ROX, a distinct spectrum was 
observed, with a decrease in 223 nm and a concomitant increase in 400 nm. The 
change of the spectral pattern clearly showed the transformation of ROX to 
products. Control groups of only CPO and H2O2 were also conducted to exclude 
the absorbance change due to addition of H2O2 and CPO. 
 
Figure 4.3 Transformation of ROX by CPO.ROX=25 µM, CPO=4.8 nM, H2O2= 0.31mM  
Phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH 3.5 
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4.3.2 The effect of pH 
The effect of pH was investigated to determine the optimal pH for CPO catalyzed 
ROX transformation (Figure 4.4).  
 
Figure 4.4 The effect of pH on ROX transformation 
ROX=25 µM, CPO=4.8 nM, H2O2= 0.69 mM Phosphate buffer: 100 mM K2HPO4, 20 mM KBr, 
pH 2.5, 3, 3.5, 4, 4.5 and 5 respectively. Monitored by UV at λ=223nm 
 
The experiment was conducted in the pH range of 2.5-5.0. In the presence of 20 
mM Br-, the optimum pH for the transformation of ROX is 3.5. The transformation 
rate gradually increased when pH increased from 2.5 to 3.5 and decresed from 
3.5 to 5.0. This trend indicated that the transformation of ROX was a 
pH-dependent process, which could be attribute to the change in the protonation 
state of the ionizable group in conpound X. Compound X was reported to be 
involved in most CPO catalyzed halide dependent reactions [53], and was able to 
release the powerful oxidizing agent (HXO) under acidic conditions. 
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4.3.3 The effect of hydrogen peroxide concentration 
To examine the effect of H2O2 concentration on the transformation of ROX, the 
experiment was carried out in the presence of varying concentrations of H2O2 
(Figure 4.5). 
Figure 4.5 The effect of H2O2 concentration on ATV transformation 
ROX=25 µM, CPO=4.8 nM, phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH=3.5, 
H2O2= 0, 0.07, 0.17, 0.34, 0.52, 0.69, 1.03 and 1.38 mM respectively. 
 Monitored by UV at λ=223nm 
As expected, there is no transformation observed without the addition of H2O2. 
The rate of transformation is greatly enhanced as the concentration of H2O2 
increased up to 0.69 mM. However, further increase in H2O2 concentration (from 
0.69 to 1.38 mM) decreased the reaction rate. The possible explanation could be 
that excess H2O2 deactivates the enzyme by forming a highly reactive iron peroxyl 
species which leads to heme degradation [62]. Thus, low concentrations of H2O2 
is applied for CPO induced transformation of ROX. 
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4.3.4 Michaelis-Menten kinetics 
CPO-catalyzed degradations generally follow Michaelis-Menten kinetics, an 
established model of single substrate kinetics showing the relation between the 
substrate concentration and reaction rate. The form of Michaelis-Menten equation 
is given as: 
V =
𝑉𝑚𝑎𝑥 × [𝑆]
𝐾𝑚 + [𝑆]
 
Where S is the concentration of the substrate (ROX), V is the initial reaction rate 
measured in the linear range of transformation. Vmax is the maximum rate that can 
be achieved by the system and Km is the substrate concentration at which the 
reaction rate is half of Vmax. Km, known as the Michaelis constant, indicates the 
affinity of the substrate to the enzyme, and the value depends on both of them, as 
well as conditions such as pH and temperature. 
 
1
𝑉
=
𝐾𝑚
𝑉𝑚𝑎𝑥
×
1
[𝑆]
+
1
𝑉𝑚𝑎𝑥
 
 
                                                                                           
Figure 4.6 Lineweaver–Burk plot 
Lineweaver-Burk plot was used to calculate Michaelis-Menten constant (Km) and 
maximum reaction rate (Vmax). Plotting the inverse of substrate concentration and 
initial rate, yields a straight line that permits the determination of Km and Vmax. 
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To conduct the experiment, different concentrations of ROX were dissolved in the 
buffer solution. Initial transformation rates were calculated by monitoring 
absorbance at 223 nm from 12-24 seconds. 
 
Figure 4.7 Michaelis-Menten kinetics 
CPO=4.8 nM, H2O2= 0.69 mM, phosphate buffer: 100 mM K2HPO4, 20 mM KBr, pH=3.5, 
ROX= 0, 5.1, 6.3, 12.7, 25.3, 38.0, 50.7, 76.0, and 101.4 µM respectively. 
Monitored by UV at λ=223nm 
From the plot, the kinetic parameter were obtained with a Michaelis-Menten 
constant (Km) of 23.61 µM and maximum reaction rate (Vmax) of 3.98 µM min-1. 
Based on the parameter calculated, turnover number can be determined to give 
the maximum number of conversions of substrate molecules per second that a 
single catalytic site will execute for a given enzyme concentration.  
𝑘𝑐𝑎𝑡 =
𝑉𝑚𝑎𝑥
[𝐸]𝑇
 
Vmax is the maximum rate and [E]T is the concentration of catalyst (CPO). 
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4.3.5 Product identification 
NMR and mass analyses were employed to establish the structure of the products 
from CPO-catalyzed transformation of ROX. The proton NMR spectra are shown 
in Figure 4.8. The mass spectra are shown in Figure 4.9. 
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The transformation of ROX was confirmed by NMR and mass analysis of the 
reaction products. The NMR spectra suggested the formation of three products 
and two of them were shown on the mass spectra. The molecular ion detected on 
mass indicated the addition of two bromine atom to the parent compound, since a 
1:2:1 ratio of M:M+2:M+4 peaks is the isotopic signature of two bromine. The 
single bromination product was not observed in mass spectrum but gave two 
doublets at 7.98 and 8.16 ppm in NMR with a coupling constant around 4, which 
indicates the addition of one bromine to the meta carbon of the hydroxyl group. 
The 264, 266 and 268 m/z ratio, together with the single peak in NMR at 8.11 ppm 
are consistent with the formation of a di-brominated product. Two positions exist 
as another bromine can be added at the benzene ring. However, the meta 
position carbon of the nitro group is less preferred because of the effect of steric 
hindrance and electronic directing effect of the nitro group. Therefore, the addition 
is proposed to be at the para position of the nitro group. The coupling pattern of 
this product indicates the hydroxylation of the nitro group, resulting in a doublet of 
doublets and two doublets in NMR, giving 264, 266 and 268 m/z ratio in mass 
spectra with two bromine added. The molecular ions are not shown in the mass 
spectra for the easily decomposed characteristic of ROX and related metabolites. 
However, the fragmentation ions observed is in good agreement with the products 
proposed by NMR.   
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4.3.6 Mechanism of CPO-catalyzed roxarsone transformation 
Based on the products identified from NMR and mass spectroscopic studies, a 
mechanism of CPO-catalyzed transformation of ROX is proposed (Figure 4.10). 
 
Figure 4.10 Proposed mechanism of ATV transformation (C=Cl- or Br-) 
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4.4 Conclusion  
In this work, we found that ROX is effectively transformed by CPO. The 
transformation can be achieved over a range of acidic pH (2.5 to 5) with the 
fastest transformation observed at pH = 3.5. The conversion required H2O2 with 
an optimal concentration range of 0.4-1 mM. The CPO catalyzed transformation 
of ROX followed Michaelis-Menten kinetics, with an Km of 23.61 µM and Vmax of 
3.98 µM min-1. These parameters can be used as a measure for the preference of 
CPO to ROX and also to evaluate the effectiveness of the enzyme. 
 
Both NMR and MS analyses demonstrated the bromination and hydroxylation of 
aromatic ring in ROX, showing the regioselectivity of CPO catalysis. During 
bromination, CPO converts ROX to either monobrominated (3-bromo-4-hydroxy-5
-nitrophenyl arsonic acid) or dibrominated (2,3-dibromo-4-hydroxy-5-nitrophenyl 
arsonic acid) products while the nitro group of ROX is hydroxylated. Based on the 
product identified, the mechanism of CPO-catalyzed transformation of ROX is 
proposed. The CPO-hypohalous acid complex is critical in the transformation in 
the proposed mechanism. The product analysis not only provides a better 
understanding of CPO catalyzed reactions, but also helps to evaluate the 
potential of this enzymatic method in environmental applications. While the 
process does not lead to mineralization, the observed product may be less toxic, 
more soluble, and more susceptible to further remediation processes.  
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In general, the study provides a foundation for assessing the feasibility of applying 
CPO in the transformation of ROX contaminated water and soils for its high 
efficiency, cost-effectiveness and environmental friendly nature. This study also 
provides evidence about the general bromination mechanisms, which has 
promising potential in environmental applications. However, there are limitations 
such as the requirement for acidic conditions and the limited commercial 
availability of CPO. 
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